Compound reference

IGF-1 LR3

A modified, longer-acting analog of insulin-like growth factor-1 (IGF-1), studied in animals for muscle growth and protein synthesis.

Updated October 2026 · 3 minute read
This page is an educational reference, not medical advice. IGF-1 LR3 is a research reagent and is not approved by the FDA for human use.

What it is

IGF-1 LR3 (Long R3 insulin-like growth factor-1) is an extended-half-life analog of IGF-1, a growth factor involved in tissue growth. It is studied preclinically for muscle hyperplasia (an increase in the number of muscle cells), protein synthesis and recovery.

IGF-1 biology itself is extensively studied, but the LR3 analog is a research reagent rather than a clinical drug. In the PeptidesAI encyclopedia it is categorized under growth hormone.

How it's thought to work

It binds IGF-1 receptors to drive protein synthesis, cell proliferation and satellite-cell activation, where satellite cells are the stem cells of muscle tissue. The LR3 modification reduces its binding to IGF-binding proteins, the blood proteins that bind and carry IGF-1, and is described as greatly extending its half-life and activity.

In a rat study, IGF-1 variants that bind poorly to IGF-binding proteins, including LR3, were about 2.5-fold more potent than IGF-1 at reversing the body weight loss and nitrogen loss produced by a corticosteroid.

What the research says

IGF-1 biology is extensively studied; the LR3 analog itself is a research reagent, not a clinical drug. The published work on LR3 cited here is in animals.

In pigs, IGF-1 variants with reduced affinity for IGF-binding proteins, including LR3, lowered blood glucose 2- to 3-fold more strongly than IGF-1, and over a longer period.

Reported side effects

Reported side effects include hypoglycemia (low blood sugar), headache and injection site reactions. A theoretical concern is that strong growth signaling could promote unwanted tissue growth. The animal glucose-lowering findings above are consistent with the hypoglycemia concern.

Reconstitution

IGF-1 LR3 is supplied as a lyophilized (freeze-dried) powder and is typically reconstituted with bacteriostatic (BAC) water before use. It commonly comes in 1 mg vials. The amount of peptide in the vial is fixed; the water added only changes how concentrated the solution is.

Worked example. A 1 mg vial is 1,000 mcg. Reconstituted with 1 mL of BAC water, that works out to 1,000 mcg ÷ 1 mL = 1,000 mcg/mL. On a U-100 insulin syringe, where each unit is 0.01 mL, each unit holds 1,000 × 0.01 = 10 mcg. Use the peptide reconstitution calculator to work out the concentration and units for any vial size and water volume.

Important notes

IGF-1 LR3 is a growth factor with significant safety considerations, including hypoglycemia and a theoretical risk of tissue growth. It is not FDA-approved and is listed as prohibited by the World Anti-Doping Agency (WADA).

Sources

  1. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Tomas FM et al. Biochemical Journal, 1992. Preclinical
  2. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. Tomas FM et al. Journal of Endocrinology, 1997. Preclinical

How we choose and check sources

Frequently asked questions

These questions cover the same ground as the sections above, in a shorter format.

What is IGF-1 LR3?

An extended-half-life analog of IGF-1, studied preclinically for muscle hyperplasia, protein synthesis and recovery.

How is IGF-1 LR3 thought to work?

It binds IGF-1 receptors to drive protein synthesis, cell proliferation and satellite-cell activation, and its reduced binding to IGF-binding proteins is described as extending its half-life and activity.

What does the research on IGF-1 LR3 say?

IGF-1 biology is extensively studied, but LR3 itself is a research reagent; the published work cited here is in animals, where LR3 and similar variants were more potent than IGF-1.

What are the reported side effects of IGF-1 LR3?

Hypoglycemia, headache and injection site reactions, plus a theoretical concern about unwanted tissue growth.

How much is one unit from a 1 mg IGF-1 LR3 vial?

With 1 mL of BAC water, a 1 mg vial is 1,000 mcg/mL, so one unit on a U-100 syringe (0.01 mL) holds 10 mcg.

The full entry, plus the calculator

The PeptidesAI app has the complete encyclopedia entry for IGF-1 LR3 — one of 70 compounds covered — plus the reconstitution calculator, a dose log and reminders. Free to download on iPhone.

Download on the App Store

Related